125th MAINE LEGISLATURE
		LD 1840		LR 2680(01)
	An Act To Limit MaineCare Reimbursement for Methadone Treatment
	Preliminary Fiscal Impact Statement for Original Bill
	Sponsor: Rep. Burns of Whiting
	Committee: Health and Human Services
	Fiscal Note Required: Yes
Preliminary Fiscal Impact Statement
			FY 2011-12	FY 2012-13	Projections  FY 2013-14	Projections  FY 2014-15
Net Cost (Savings)
	General Fund		$0	($1,492,428)	($2,984,856)	($2,984,856)
Appropriations/Allocations
	General Fund		$0	($1,492,428)	($2,984,856)	($2,984,856)
	Federal Expenditures Fund		$0	($2,514,090)	($5,028,179)	($5,028,179)
Revenue
	Federal Expenditures Fund		$0	($2,514,090)	($5,028,179)	($5,028,179)
Fiscal Detail and Notes
	The General Fund savings associated with limiting MaineCare reimbursement for methadone for the treatment of addiction to opiods to a lifetime maximum of 24 months is estimated to be $1,492,428 in fiscal year 2012-13.  The Federal Expenditures Fund share of the savings is estimated to be $2,514,090 in fiscal year 2012-13.